These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 9178811)
1. Chromosome 16 in primary prostate cancer: a microsatellite analysis. Osman I; Scher H; Dalbagni G; Reuter V; Zhang ZF; Cordon-Cardo C Int J Cancer; 1997 May; 71(4):580-4. PubMed ID: 9178811 [TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions. Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer. Jenkins R; Takahashi S; DeLacey K; Bergstralh E; Lieber M Genes Chromosomes Cancer; 1998 Feb; 21(2):131-43. PubMed ID: 9491325 [TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions. Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263 [TBL] [Abstract][Full Text] [Related]
5. Microsatellite instability and deletion analysis of chromosome 10 in human prostate cancer. Lacombe L; Orlow I; Reuter VE; Fair WR; Dalbagni G; Zhang ZF; Cordon-Cardo C Int J Cancer; 1996 Apr; 69(2):110-3. PubMed ID: 8608977 [TBL] [Abstract][Full Text] [Related]
6. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers. Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631 [TBL] [Abstract][Full Text] [Related]
7. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Cher ML; MacGrogan D; Bookstein R; Brown JA; Jenkins RB; Jensen RH Genes Chromosomes Cancer; 1994 Nov; 11(3):153-62. PubMed ID: 7530484 [TBL] [Abstract][Full Text] [Related]
10. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers. Suzuki H; Komiya A; Emi M; Kuramochi H; Shiraishi T; Yatani R; Shimazaki J Genes Chromosomes Cancer; 1996 Dec; 17(4):225-33. PubMed ID: 8946204 [TBL] [Abstract][Full Text] [Related]
11. Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers. Dorion-Bonnet F; Mautalen S; Hostein I; Longy M Genes Chromosomes Cancer; 1995 Nov; 14(3):171-81. PubMed ID: 8589033 [TBL] [Abstract][Full Text] [Related]
12. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Carter BS; Ewing CM; Ward WS; Treiger BF; Aalders TW; Schalken JA; Epstein JI; Isaacs WB Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8751-5. PubMed ID: 1978938 [TBL] [Abstract][Full Text] [Related]
13. Genetic alteration mapping on chromosome 7 in primary breast cancer. Bièche I; Khodja A; Driouch K; Lidereau R Clin Cancer Res; 1997 Jun; 3(6):1009-16. PubMed ID: 9815778 [TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma. Ittmann MM Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052 [TBL] [Abstract][Full Text] [Related]
15. Chromosomal basis of adenocarcinoma of the prostate. Verma RS; Manikal M; Conte RA; Godec CJ Cancer Invest; 1999; 17(6):441-7. PubMed ID: 10434955 [TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability and other molecular abnormalities in human prostate cancer. Suzuki H; Komiya A; Aida S; Akimoto S; Shiraishi T; Yatani R; Igarashi T; Shimazaki J Jpn J Cancer Res; 1995 Oct; 86(10):956-61. PubMed ID: 7493915 [TBL] [Abstract][Full Text] [Related]
17. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067 [TBL] [Abstract][Full Text] [Related]
18. P53 mutations and loss of heterozygosity on chromosomes 8p, 16q, 17p, and 18q are confined to advanced prostate cancer. Massenkeil G; Oberhuber H; Hailemariam S; Sulser T; Diener PA; Bannwart F; Schäfer R; Schwarte-Waldhoff I Anticancer Res; 1994; 14(6B):2785-90. PubMed ID: 7872719 [TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. Trapman J; Sleddens HF; van der Weiden MM; Dinjens WN; Konig JJ; Schroder FH; Faber PW; Bosman FT Cancer Res; 1994 Dec; 54(23):6061-4. PubMed ID: 7954446 [TBL] [Abstract][Full Text] [Related]
20. Differential chromosome allelic imbalance in the progression of human prostate cancer. Latil A; Fournier G; Cussenot O; Lidereau R J Urol; 1996 Dec; 156(6):2079-83. PubMed ID: 8911394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]